Vestal Point Capital »

Immatics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Immatics (IMTX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Immatics

Tip: Access up to 7 years of quarterly data

All positions including Immatics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immatics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $32M 2.8M 11.62

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Immatics

Rtw Investments
Wellington Management Company
Perceptive Advisors
T. Rowe Price Investment Management
Baker Bros. Advisors
T. Rowe Price Associates
Paradigm Biocapital Advisors
Woodline Partners
Vestal Point Capital
OrbiMed Advisors
Goldman Sachs Group
RA Capital Management
Frazier Life Sciences Management
Citadel Advisors
Suvretta Capital Management

View all funds holding Immatics